Deerfield Healthcare Technology (DFHT) Shareholders Approve CareMax Medical Group Deal
by Marlena Haddad on 2021-06-05 at 4:12pm

Deerfield Healthcare Technology. (NASDAQ:DFHT) announced that its shareholders have approved its business combination with CareMax with the much-coveted zero-redemption vote at a special meeting Friday.

The parties expect to close the transaction Tuesday, June 8, after which CareMax and IMC will become wholly owned subsidiaries of Deerfield, which will be renamed CareMax. The combined company’s shares and warrants will commence trading Wednesday, June 9 on the Nasdaq under the new trading symbols “CMAX” and “CMAXW”, respectively.

This marks nine out of ten positive votes and completions since May 1 (90% positive rate), with Deerfield opening June 2, the day of its redemption deadline, at $14.45. That made it an easy decision for investors to hold onto their shares.

Deerfield and CareMax initially announced their $692 million deal on December 18.  Since its founding in 2011, CareMax has built its practice based on proactively fulfilling members’ medical, mental and social needs – something the company calls “whole person health”, that leads to improved patient health and lower costs to the healthcare system.

The SPAC noted that all other measures on the ballot including the combined company’s incentive plan were also approved, but full tallies will not be available until it files an 8-K detailing the vote.


ADVISORS

  • Deutsche Bank Securities Inc. and UBS Investment Bank are acting as financial advisors and capital markets advisors to DFHT.
  • Morgan Stanley & Co. LLC is acting as financial advisor to CareMax Medical Centers and Piper Sandler is acting as financial advisor to IMC Health.
  • White & Case LLP and Polsinelli PC are acting as legal advisors to DFHT.
  • DLA Piper LLP (US) is acting as legal advisor to CareMax Medical Centers.
  • McDermott Will & Emery LLP is acting as legal advisor to IMC Health.
  • Katten Muchin Rosenman LLP is acting as legal advisor to Deerfield.
Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved